Resurgence of Diabetes-Related Nontraumatic Lower-Extremity Amputation in the Young and Middle-Aged Adult U.S. Population
- PMID: 30409811
- DOI: 10.2337/dc18-1380
Resurgence of Diabetes-Related Nontraumatic Lower-Extremity Amputation in the Young and Middle-Aged Adult U.S. Population
Abstract
Objective: To determine whether declining trends in lower-extremity amputations have continued into the current decade.
Research design and methods: We calculated hospitalization rates for nontraumatic lower-extremity amputation (NLEA) for the years 2000-2015 using nationally representative, serial cross-sectional data from the Nationwide Inpatient Sample on NLEA procedures and from the National Health Interview Survey for estimates of the populations with and without diabetes.
Results: Age-adjusted NLEA rates per 1,000 adults with diabetes decreased 43% between 2000 (5.38 [95% CI 4.93-5.84]) and 2009 (3.07 [95% CI 2.79-3.34]) (P < 0.001) and then rebounded by 50% between 2009 and 2015 (4.62 [95% CI 4.25-5.00]) (P < 0.001). In contrast, age-adjusted NLEA rates per 1,000 adults without diabetes decreased 22%, from 0.23 per 1,000 (95% CI 0.22-0.25) in 2000 to 0.18 per 1,000 (95% CI 0.17-0.18) in 2015 (P < 0.001). The increase in diabetes-related NLEA rates between 2009 and 2015 was driven by a 62% increase in the rate of minor amputations (from 2.03 [95% CI 1.83-2.22] to 3.29 [95% CI 3.01-3.57], P < 0.001) and a smaller, but also statistically significant, 29% increase in major NLEAs (from 1.04 [95% CI 0.94-1.13] to 1.34 [95% CI 1.22-1.45]). The increases in rates of total, major, and minor amputations were most pronounced in young (age 18-44 years) and middle-aged (age 45-64 years) adults and more pronounced in men than women.
Conclusions: After a two-decade decline in lower-extremity amputations, the U.S. may now be experiencing a reversal in the progress, particularly in young and middle-aged adults.
© 2018 by the American Diabetes Association.
Similar articles
-
National and State-Level Trends in Nontraumatic Lower-Extremity Amputation Among U.S. Medicare Beneficiaries With Diabetes, 2000-2017.Diabetes Care. 2020 Oct;43(10):2453-2459. doi: 10.2337/dc20-0586. Epub 2020 Jul 28. Diabetes Care. 2020. PMID: 32723844 Free PMC article.
-
Trends of Nontraumatic Lower-Extremity Amputation in End-Stage Renal Disease and Diabetes: United States, 2000-2015.Diabetes Care. 2019 Aug;42(8):1430-1435. doi: 10.2337/dc19-0296. Epub 2019 May 29. Diabetes Care. 2019. PMID: 31142496 Free PMC article.
-
Declining rates of hospitalization for nontraumatic lower-extremity amputation in the diabetic population aged 40 years or older: U.S., 1988-2008.Diabetes Care. 2012 Feb;35(2):273-7. doi: 10.2337/dc11-1360. Diabetes Care. 2012. PMID: 22275440 Free PMC article.
-
Gender differences in diabetes-related lower extremity amputations.Clin Orthop Relat Res. 2011 Jul;469(7):1951-5. doi: 10.1007/s11999-010-1735-4. Clin Orthop Relat Res. 2011. PMID: 21161738 Free PMC article. Review.
-
Lower extremity amputations--a review of global variability in incidence.Diabet Med. 2011 Oct;28(10):1144-53. doi: 10.1111/j.1464-5491.2011.03279.x. Diabet Med. 2011. PMID: 21388445 Review.
Cited by
-
Development and validation of a clinical prediction rule for development of diabetic foot ulceration: an analysis of data from five cohort studies.BMJ Open Diabetes Res Care. 2021 May;9(1):e002150. doi: 10.1136/bmjdrc-2021-002150. BMJ Open Diabetes Res Care. 2021. PMID: 34035053 Free PMC article.
-
Optimizing Peripandemic Care for Veteran Major Non-Traumatic Lower Extremity Amputees: A Proposal Informed by a National Retrospective Descriptive Analysis of COVID-19 Risk Factor Prevalence.Mil Med. 2020 Dec 30;185(11-12):e2124-e2130. doi: 10.1093/milmed/usaa180. Mil Med. 2020. PMID: 32601682 Free PMC article.
-
N-Acetylcysteine Enhances the Recovery of Ischemic Limb in Type-2 Diabetic Mice.Antioxidants (Basel). 2022 May 31;11(6):1097. doi: 10.3390/antiox11061097. Antioxidants (Basel). 2022. PMID: 35739993 Free PMC article.
-
Outpatient Parenteral Antibiotic Therapy for Diabetic Foot Osteomyelitis in an Uninsured and Underinsured Cohort.Infect Dis Clin Pract (Baltim Md). 2023 Mar;31(2):e1219. doi: 10.1097/ipc.0000000000001219. Epub 2023 Jan 10. Infect Dis Clin Pract (Baltim Md). 2023. PMID: 37520685 Free PMC article.
-
Primary results of the SAVAL randomized trial of a paclitaxel-eluting nitinol stent versus percutaneous transluminal angioplasty in infrapopliteal arteries.Vasc Med. 2023 Dec;28(6):571-580. doi: 10.1177/1358863X231199489. Epub 2023 Oct 16. Vasc Med. 2023. PMID: 37844137 Free PMC article. Clinical Trial.